WHO discontinues Hydroxychloroquine, Lopinavir and Ritonavir.

The World Health Organization on Saturday announced that it is discontinuing solidarity trials for therapeutics Hydroxychloroquine, Lopinavir and Ritonavir. WHO said that interim results from solidarity trials show Hydroxychloroquine and HIV drug Lopinavir/Ritonavir “produce little or no reduction in mortality of hospitalized Covid-19 patients”.
Updated by Nancy Singh
For more daily updates click here.
